Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.
暂无分享,去创建一个
Georg Schett | Thomas Harrer | Jonas Hahn | T. Harrer | A. Mócsai | R. Holmdahl | G. Schett | J. Hahn | M. Herrmann | C. Maueröder | L. Munoz | M. Podolska | D. Kienhöfer | V. Urbonaviciute | M. Hultqvist | M. Hoffmann | Rikard Holmdahl | M. Leppkes | P. Olofsson | Malin Hultqvist | Peter Olofsson | Attila Mocsai | Martin Herrmann | M. Biermann | Luis E Munoz | Moritz Leppkes | Christian Maueröder | Christiane Reinwald | Deborah Kienhöfer | Julia Stoof | Janka Zsófia Csepregi | Vilma Urbonaviciute | Caroline Johnsson | Malgorzata J Podolska | Mona H Biermann | Markus H Hoffmann | J. Csepregi | Julia Stoof | C. Reinwald | Caroline Johnsson | C. Johnsson | Christian Maueröder | Mona H. C. Biermann
[1] J. Hodgin,et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.
[2] P. Kubes,et al. NETosis: how vital is it? , 2013, Blood.
[3] M. Walport,et al. The role of complement in the development of systemic lupus erythematosus. , 2004, Annual review of immunology.
[4] M. Vilardell‐Tarrés,et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. , 2004, The American journal of medicine.
[5] Michael R. Lindberg,et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.
[6] A. Bengtsson,et al. Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus , 2014, Arthritis Research & Therapy.
[7] Felipe Andrade,et al. A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination , 2016, Front. Immunol..
[8] P. Newburger,et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. , 2001, Blood.
[9] Deepak Poudyal,et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[10] R. Holmdahl,et al. Mannan induces ROS-regulated, IL-17A–dependent psoriasis arthritis-like disease in mice , 2014, Proceedings of the National Academy of Sciences.
[11] Tomoki Ito,et al. Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus , 2011, Science Translational Medicine.
[12] L. Bäckdahl,et al. Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation , 2016, Immunological reviews.
[13] W. Nauseef. Assembly of the phagocyte NADPH oxidase , 2004, Histochemistry and Cell Biology.
[14] L. Zhan,et al. P47phox ‐deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J‐m db/db and db/+ , 2000, Journal of leukocyte biology.
[15] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[16] M. Satoh,et al. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. , 2009, Trends in immunology.
[17] R. Holmdahl,et al. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Shlomchik,et al. NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus , 2012, Science Translational Medicine.
[19] C. Dahlgren,et al. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. , 1996, Free radical biology & medicine.
[20] L. Moldawer,et al. A Novel Type I IFN-Producing Cell Subset in Murine Lupus1 , 2008, The Journal of Immunology.
[21] H. Simon,et al. NETosis – Does It Really Represent Nature’s “Suicide Bomber”? , 2016, Front. Immunol..
[22] R. Holmdahl,et al. Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils , 2012, Autoimmunity.
[23] A. Barron,et al. No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis , 2014, PloS one.
[24] J. Grande,et al. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. , 2007, Rheumatology.
[25] A. Kumar,et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] L. Joosten,et al. Neutrophil-Mediated Inhibition of Proinflammatory Cytokine Responses , 2012, The Journal of Immunology.
[27] C. Movitz,et al. Oxygen radical production and severity of the Guillain–Barré syndrome , 2007, Journal of Neuroimmunology.
[28] Y. Kuroda,et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). , 2006, The American journal of pathology.
[29] C. Daniel,et al. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. , 2013, Arthritis and rheumatism.
[30] J. Kotlerman,et al. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study , 2007, Environmental health : a global access science source.
[31] C. Allis,et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation , 2009, The Journal of cell biology.
[32] M. Turner,et al. Chronic granulomatous disease as a risk factor for autoimmune disease. , 2008, The Journal of allergy and clinical immunology.
[33] M. Satoh,et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane , 2000, Clinical and experimental immunology.
[34] A Kavanaugh,et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.
[35] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] You-Wen He,et al. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. , 2007, Blood.
[37] R. Lahesmaa,et al. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. , 2014, Antioxidants & redox signaling.
[38] Carolyne Smith,et al. The role of neutrophils in the pathogenesis of systemic lupus erythematosus , 2015, Current opinion in rheumatology.
[39] F. Silvestris,et al. Induction of Apoptosis by the Hydrocarbon Oil Pristane: Implications for Pristane-Induced Lupus1 , 2005, The Journal of Immunology.
[40] Jens Holmberg,et al. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats , 2003, Nature Genetics.
[41] T. Harrer,et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines , 2014, Nature Medicine.
[42] R. Holmdahl,et al. Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions. , 2014, Antioxidants & redox signaling.
[43] Sai Kumar Chakka,et al. Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model. , 2013, Journal of medicinal chemistry.
[44] Abdul Hakkim,et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis , 2010, Proceedings of the National Academy of Sciences.
[45] A. Mócsai,et al. Reply to "Neutrophils are not required for resolution of acute gouty arthritis in mice" , 2016, Nature Medicine.
[46] Don L. Armstrong,et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase , 2011, Proceedings of the National Academy of Sciences.
[47] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[48] M. Radic,et al. Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release , 2013, Front. Immun..
[49] K. Goss,et al. NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome. , 2014, American journal of physiology. Lung cellular and molecular physiology.
[50] R. Holmdahl,et al. Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation , 2013, Journal of leukocyte biology.
[51] M. Satoh,et al. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane , 1994, The Journal of experimental medicine.
[52] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[53] Matthias Kretzler,et al. Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.
[54] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[55] K. Elkon,et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease , 2015, Nature Medicine.
[56] S. Bombardieri,et al. Anti-Sm and anti-RNP antibodies , 2005, Autoimmunity.
[57] Ec Beachler. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003 .
[58] M. Martusewicz-Boros,et al. [Pulmonary manifestations of systemic lupus erythematosus]. , 2002, Pneumonologia i alergologia polska.
[59] R. Voskuhl,et al. A female preponderance for chemically induced lupus in SJL/J mice. , 2007, Clinical immunology.
[60] B. Croker,et al. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. , 2003, Kidney international.
[61] P. Thompson,et al. Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis , 2014, Circulation research.
[62] C. Carmona-Rivera,et al. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity , 2013, Seminars in Immunopathology.
[63] R. Cervera,et al. 1982 Revised Criteria for Classification of Systemic Lupus Erythematosus — Ten Years Later , 1993, Lupus.
[64] HolmdahlRikard,et al. Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions , 2014 .
[65] L. Joosten,et al. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. , 2003, The American journal of pathology.